A Preview Of Mersana Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
Mersana Therapeutics (NASDAQ:MRSN) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $-0.16. Investors are looking for an earnings beat and positive guidance for the next quarter. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat followed by a 2.99% drop. Shares are currently trading at $4.06, down 26.76% over the last year, indicating a bearish sentiment among long-term shareholders.
February 27, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Mersana Therapeutics is expected to report an EPS of $-0.16 for the upcoming earnings, with investors hoping for positive guidance. The stock has seen a 26.76% decline over the past year, indicating bearish sentiment.
The short-term impact on MRSN's stock price will likely depend on whether the company beats the EPS estimate and provides positive guidance. Given the stock's recent performance and the bearish sentiment among long-term shareholders, the reaction to the earnings report could be muted unless there's a significant positive surprise. Historical data shows mixed reactions to past earnings, making it challenging to predict the exact direction of the stock price movement post-earnings.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100